Insulet Corp
NASDAQ:PODD
Intrinsic Value
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. [ Read More ]
The intrinsic value of one PODD stock under the Base Case scenario is 84.86 USD. Compared to the current market price of 161.36 USD, Insulet Corp is Overvalued by 47%.
Valuation Backtest
Insulet Corp
Run backtest to discover the historical profit from buying and selling PODD stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Insulet Corp
Current Assets | 1.6B |
Cash & Short-Term Investments | 650.7m |
Receivables | 359.7m |
Other Current Assets | 572.5m |
Non-Current Assets | 1B |
PP&E | 692.8m |
Intangibles | 150.4m |
Other Non-Current Assets | 162.1m |
Current Liabilities | 451.2m |
Accounts Payable | 19.2m |
Accrued Liabilities | 377.8m |
Other Current Liabilities | 54.2m |
Non-Current Liabilities | 1.4B |
Long-Term Debt | 1.4B |
Other Non-Current Liabilities | 37.9m |
Earnings Waterfall
Insulet Corp
Revenue
|
1.7B
USD
|
Cost of Revenue
|
-537.2m
USD
|
Gross Profit
|
1.2B
USD
|
Operating Expenses
|
-939.9m
USD
|
Operating Income
|
220m
USD
|
Other Expenses
|
-13.7m
USD
|
Net Income
|
206.3m
USD
|
Free Cash Flow Analysis
Insulet Corp
PODD Profitability Score
Profitability Due Diligence
Insulet Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Insulet Corp's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
PODD Solvency Score
Solvency Due Diligence
Insulet Corp's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Score
Insulet Corp's solvency score is 56/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PODD Price Targets Summary
Insulet Corp
According to Wall Street analysts, the average 1-year price target for PODD is 241.57 USD with a low forecast of 210.08 USD and a high forecast of 283.5 USD.
Ownership
PODD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
PODD Price
Insulet Corp
Average Annual Return | 41.43% |
Standard Deviation of Annual Returns | 46.16% |
Max Drawdown | -61% |
Market Capitalization | 11.3B USD |
Shares Outstanding | 70 022 496 |
Percentage of Shares Shorted | 5.26% |
PODD News
Last Important Events
Insulet Corp
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Insulet Corp
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts and currently employs 2,300 full-time employees. The company went IPO on 2007-05-15. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. The company can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.
Contact
IPO
Employees
Officers
The intrinsic value of one PODD stock under the Base Case scenario is 84.86 USD.
Compared to the current market price of 161.36 USD, Insulet Corp is Overvalued by 47%.